Related Experiment Video
Updated: Aug 15, 2026
Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction
Published on: June 29, 2013
Physiology and management of intrauterine growth retardation: a biologic approach with fetal blood sampling
W L Cox1, F Daffos, F Forestier
1Centre de Diagnostic Prénatal et de Foetologie, Institut de Puericulture de Paris, France.
Insights
Intrauterine growth retardation (IUGR) poses risks to newborns. Fetal blood tests reveal anemia, red blood cell destruction, liver damage, and acid-base imbalances in fetuses with IUGR, aiding clinical management.
Area of Science:
- Perinatal Medicine
- Fetal Physiology
- Neonatal Health
Background:
- Intrauterine growth retardation (IUGR) is a significant cause of perinatal mortality and morbidity.
- Assessing fetal well-being and risk in utero is crucial for optimal delivery timing.
- Current methods rely on subjective clinical assessments.
Purpose of the Study:
- To provide objective hematologic and biochemical data for managing fetuses with idiopathic IUGR.
- To identify specific fetal markers indicative of compromised health status.
Main Methods:
- Fetal blood sampling was performed on 24 fetuses diagnosed with idiopathic IUGR.
- Hematologic and biochemical parameters were analyzed.
Main Results:
- Evidence of stimulated erythropoiesis (red blood cell production) was observed.
- Signs of red blood cell destruction and liver damage were detected.
- Many fetuses exhibited acute decompensation with acid-base abnormalities alongside chronic changes.
Conclusions:
- Fetal blood analysis offers objective insights into the pathophysiology of IUGR.
- These findings can inform clinical decisions regarding delivery timing and management.
- IUGR is associated with complex hematologic, biochemical, and acid-base disturbances.
Abstract:
Intrauterine growth retardation is a major contributor to perinatal mortality and morbidity. The most important obstetric problem is to determine which fetuses are well in utero and which are at risk of irreversible damage or severe and prolonged neonatal morbidity. The optimal timing of delivery is at present made by subjective assessment of clinical variables. We present hematologic and biochemical values obtained by fetal blood sampling of 24 idiopathic fetuses with intrauterine growth retardation to give objective information on which to base clinical management. The results show that there is stimulation of erythropoiesis as well as evidence of red blood cell destruction and liver damage. In many cases there is acute decompensation with acid base abnormalities in a setting of chronic hematologic and biochemical changes.
